CIK 0001453593 · Non-accelerated filer<br>Smaller reporting company
Xtant Medical Holdings, Inc.
Sign in to watch- Ticker
- XTNT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205313323
- Phone
- 406-388-0480
- Business address
- 664 CRUISER LANE, BELGRADE, MT, 59714
- Former names
- Bacterin International Holdings, Inc., K KITZ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-17 | Rizzo Matthew Director | Option exercise · Warrant (right to buy) | −434,008 | 0 | ||
| 2020-11-17 | Rizzo Matthew Director | Option exercise · Warrant (right to buy) | −765,992 | 0 | ||
| 2020-11-17 | Rizzo Matthew Director | Option exercise · Warrant (right to buy) | −434,008 | 0 | ||
| 2020-11-17 | Rizzo Matthew Director | Option exercise · Warrant (right to buy) | −1,531,984 | 0 | ||
| 2020-11-17 | Rizzo Matthew Director | Option exercise · Warrant (right to buy) | −868,016 | 0 | ||
| 2020-11-15 | Browne Sean E President and Chief Executive | Grant or award | +1,468,859 | 1,797,903 | ||
| 2020-11-15 | Browne Sean E President and Chief Executive | Grant or award · Stock Option | +1,468,859 | 1,468,859 | ||
| 2020-10-01 | Eggenberg Michael Director | Grant or award | +46,784,775 | $1.07 | $50.1M | 52,702,384 |
| 2020-10-01 | Eggenberg Michael Director | Grant or award | +11,969,619 | $1.07 | $12.8M | 15,300,688 |
| 2020-10-01 | Rizzo Matthew Director | Grant or award | +46,784,775 | $1.07 | $50.1M | 52,702,384 |
| 2020-10-01 | Rizzo Matthew Director | Grant or award | +11,969,619 | $1.07 | $12.8M | 15,300,688 |
| 2020-10-01 | ORBIMED ADVISORS LLC Director | Grant or award | +46,784,775 | $1.07 | $50.1M | 52,702,384 |
| 2020-10-01 | ORBIMED ADVISORS LLC Director | Grant or award | +11,969,619 | $1.07 | $12.8M | 15,300,688 |
| 2020-08-15 | JENSEN GREG VP, Finance and CFO | Grant or award | +95,183 | 129,081 | ||
| 2020-08-15 | JENSEN GREG VP, Finance and CFO | Grant or award · Stock Option (right to buy) | +119,942 | 119,942 | ||
| 2020-08-15 | Brandt Kevin D Chief Commercial Officer | Grant or award | +95,183 | 170,352 | ||
| 2020-08-15 | Brandt Kevin D Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +119,942 | 119,942 | ||
| 2020-05-06 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +1,531,984 | 1,531,984 | ||
| 2020-05-06 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +868,016 | 868,016 | ||
| 2020-05-06 | Rizzo Matthew Director | Grant or award · Warrant (right to buy) | +1,531,984 | 1,531,984 |
Page 8 of 9 · 177 trades